Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: implications and strategy for future "high-tech" neonatal clinical trials.
D000280:Administration, Inhalation; D002170:Canada; D006801:Humans; D007231:Infant, Newborn; D009569:Nitric Oxide / Q000008:administration & dosage*; D010547:Persistent Fetal Circulation Syndrome / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012106:Research / Q000639:trends; D014481:United States
D009569:Nitric Oxide